MyFinsight
Home
Blog
About
Contact
Download
Download image
something is missing
$3,400,000
Proceeds from issuance of
shares under the sales...
$873,702
Net cash provided by
financing activities
$2,873,702
Canceled cashflow
$1,400,000
Net increase in cash
$139,933
Canceled cashflow
$2,733,769
Proceeds from loan
agreement
-$1,400,000
Stock-based compensation
expense
$2,849,592
Accounts payable
$458,472
Depreciation expense
$30,268
Amortization of right-of-use
asset
$28,783
Net cash used in
operating activities
-$2,733,769
Canceled cashflow
$3,367,115
Net loss
-$5,446,255
Prepaid expenses and
other assets
$341,597
Accrued expenses and
other liabilities
-$258,417
Operating lease
liabilities
-$28,781
Change in fair value of
warrants
-$25,831
Other assets
$3
Back
Back
Cash Flow
source: myfinsight.com
Tevogen Bio Holdings Inc. (TVGNW)
Tevogen Bio Holdings Inc. (TVGNW)